Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge-Reference-Cited by-同舟云学术

Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

Published:2008-01-15 Issue:9 Volume:16 Page:1017-1023
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Sebban Catherine,Dussart Sophie,Fuhrmann Christine,Ghesquieres Hervé,Rodrigues Isabelle,Geoffrois Lionel,Devaux Yves,Lancry Laurence,Chvetzoff Giselle,Bachelot Thomas,Chelghoum Maria,Biron Pierre

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-007-0383-z.pdf

Reference30 articles.

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

2. Aktas Z, Gonullu N, Salcioglu M, Bal C, Ang O (2002) Moxifloxacin activity against clinical isolates compared with the activity of ciprofloxacin. Int J Antimicrob Agents 20:196–200

3. Balfour JA, Wiseman LR (1999) Moxifloxacin. Drugs 57:363–373

4. Biron P, Fuhrmann C, Cure H, Viens P, Lefebvre D, Thyss A, Viot M, Soler-Michel P, Rollin C, Gres JJ (1998) Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer). J Antimicrob Chemother 42:511–518

5. Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA (2005) Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Cancer 103:2629–2635

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ambulatory management of low-risk febrile neutropenia in adult oncological patients. Systematic review;Supportive Care in Cancer;2023-11

2. Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy;Scientific Reports;2021-09-15

3. Efficacy of oral levofloxacin monotherapy against low-risk FN in patients with malignant lymphoma who received chemotherapy using the CHOP regimen;Journal of Clinical and Experimental Hematopathology;2020

4. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?;Supportive Care in Cancer;2019-10-31

5. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event;Cochrane Database of Systematic Reviews;2019-03-19